Norwegian regulator clears NorgesGruppen acquisition of NMD
Norwegian retail group NorgesGruppen ASA (OSE:NORG) announced on Tuesday that the Norwegian Competition Authority has approved its acquisition of pharmaceuticals and healthcare products supplier Norsk Medisinaldepot AS (NMD), including the Vitusapotek and Ditt Apotek pharmacy chains, from McKesson Corporation (NYSE:MCK).
Completion of the transaction is scheduled for 31 January 2026.
Following the acquisition, one of Norway's three major pharmacy chains will be owned by a Norwegian company.
NMD operates 391 pharmacies nationwide and employs more than 3,000 people including wholesale operations. It will continue as an independent, wholly owned subsidiary of NorgesGruppen.
Runar Hollevik, CEO of NorgesGruppen, said that this transaction strengthens pharmaceutical preparedness and access to pharmacy products across Norway.
Published in
Nordic Business Report
on Tuesday, 16 December 2025
Copyright (C) 2025, M2 Communications Ltd.
Other Latest Headlines
·ABB to acquire IPEC to expand electrical monitoring and predictive maintenance capabilities (16 Dec 2025 12:01am)
·Subsea 7 awarded subsea contract for Chevron's Gorgon Stage 3 project (16 Dec 2025 12:01am)
·Kongsberg to integrate anti-drone system into Dutch air defence platforms (16 Dec 2025 12:01am)
·Alfa Laval launches LNG fuel-conditioning module for marine engines (16 Dec 2025 12:01am)